| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/06/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/06/22 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 09/02/22 | 8-K | Current report filing |
|
   |
3 |
| 08/29/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/29/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/29/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/29/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/15/22 | 8-K | Current report filing |
|
|
3 |
| 08/12/22 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
33 | |
| 08/12/22 | 8-K | Current report filing |
|
|
51 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.